cGAS/STING途径 - - 胃癌的新潜在生物治疗标?
Mengxiang Tian1,2, Shuai Zhang1, Fengbo Tan1,2
1Department of General Surgery, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha 410017, China.
胃癌生物疗法通过向cGAS-STING通路显示出有希望. 这种先天的免疫路径可以将免疫抑制的瘤环境转化为免疫刺激的瘤环境,为这种致命的癌症提供新的希望.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 胃癌是全球癌症死亡的主要原因,目前的治疗方法往往不足.
- 瘤微环境可以抑制免疫反应,需要新的治疗策略,如生物疗法.
- 干扰素基因 (STING) 途径的循环GMP-AMP合成酶 (cGAS) 刺激器是异常DNA的关键先天免疫传感器.
研究的目的:
- 审查关于胃癌中cGAS-STING通路的当前研究.
- 评估针对胃癌生物疗法的cGAS-STING途径的潜在目标.
- 讨论关于胃癌中的STING激动剂的临床试验见解.
主要方法:
- 科学出版物和临床试验数据的文献综述.
- 对cGAS-STING通路在先天免疫和癌症中的作用的分析.
- 评估涉及cGAS-STING途径的生物治疗策略.
主要成果:
- 该cGAS-STING通路识别瘤衍生的DNA并启动免疫反应.
- 激活cGAS-STING通路可以将免疫抑制瘤微环境转化为免疫刺激的微环境.
- 早期临床试验显示,在癌症治疗中,STING激动剂具有潜力.
结论:
- 该cGAS-STING通路代表了新的胃癌生物治疗的有希望的目标.
- 利用这种途径可以克服对传统疗法和免疫疗法的耐药性.
- 需要进一步的研究和临床试验,才能充分实现cGAS-STING激动剂在胃癌中的治疗潜力.
更多相关视频
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
09:24Combined Conditional Knockdown and Adapted Sphere Formation Assay to Study a Stemness-Associated Gene of Patient-derived Gastric Cancer Stem Cells
Published on: May 9, 2020
相关概念视频
Targeted Cancer Therapies
There are several types of targeted therapies against...
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
GPCRs Regulate Adenylyl Cylase Activity
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Drugs that Stabilize Microtubules
